HK1129105A1 - Pyrazolo - Google Patents

Pyrazolo

Info

Publication number
HK1129105A1
HK1129105A1 HK09107320.7A HK09107320A HK1129105A1 HK 1129105 A1 HK1129105 A1 HK 1129105A1 HK 09107320 A HK09107320 A HK 09107320A HK 1129105 A1 HK1129105 A1 HK 1129105A1
Authority
HK
Hong Kong
Prior art keywords
pyrazolo
Prior art date
Application number
HK09107320.7A
Other languages
English (en)
Inventor
Luis Anglada
Albert Palomer
Antonio Guglietta
Original Assignee
Ferrer Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrer Int filed Critical Ferrer Int
Publication of HK1129105A1 publication Critical patent/HK1129105A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK09107320.7A 2006-08-04 2009-08-10 Pyrazolo HK1129105A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US83544406P 2006-08-04 2006-08-04
EP06118454A EP1884516A1 (en) 2006-08-04 2006-08-04 Pyrazolo[1,5-a]pyrimidines, processes, uses and compositions
PCT/EP2007/058006 WO2008015253A1 (en) 2006-08-04 2007-08-02 Pyrazolo[1,5-a]pyrimidines, processes, uses and compositions

Publications (1)

Publication Number Publication Date
HK1129105A1 true HK1129105A1 (en) 2009-11-20

Family

ID=37864479

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09107320.7A HK1129105A1 (en) 2006-08-04 2009-08-10 Pyrazolo

Country Status (25)

Country Link
US (1) US8158632B2 (xx)
EP (2) EP1884516A1 (xx)
JP (1) JP2009545568A (xx)
KR (1) KR20090046916A (xx)
CN (1) CN101641359A (xx)
AR (1) AR062205A1 (xx)
AT (1) ATE469906T1 (xx)
AU (1) AU2007280412A1 (xx)
BR (1) BRPI0715169A2 (xx)
CA (1) CA2659969A1 (xx)
CL (1) CL2007002262A1 (xx)
CY (1) CY1110757T1 (xx)
DE (1) DE602007006966D1 (xx)
DK (1) DK2059521T3 (xx)
ES (1) ES2346810T3 (xx)
HK (1) HK1129105A1 (xx)
MX (1) MX2009001149A (xx)
NO (1) NO20090972L (xx)
PL (1) PL2059521T3 (xx)
PT (1) PT2059521E (xx)
RU (1) RU2458063C2 (xx)
SI (1) SI2059521T1 (xx)
TW (1) TW200815445A (xx)
UY (1) UY30521A1 (xx)
WO (1) WO2008015253A1 (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009095742A1 (en) 2008-01-31 2009-08-06 Cellectis New i-crei derived single-chain meganuclease and uses thereof
WO2010053127A1 (ja) * 2008-11-05 2010-05-14 協和発酵キリン株式会社 α1GABAA受容体またはα5GABAA受容体の調整剤
ES2540867T3 (es) * 2010-02-26 2015-07-14 Mitsubishi Tanabe Pharma Corporation Compuestos de pirazolopirimidina y su uso como inhibidores de PDE10
CN102807569B (zh) * 2012-08-21 2015-02-25 四川大学 一种镇静催眠的化合物及其制备方法和用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4626538A (en) * 1983-06-23 1986-12-02 American Cyanamid Company [7-(3-disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidines
US4847256A (en) * 1986-10-16 1989-07-11 American Cyanamid Company 4,5-dihydro and 4,5,6,7-tetrahydropyrazolo(1,5-A)-pyrimidines
EP0521622B1 (en) * 1991-07-03 1997-08-13 PHARMACIA & UPJOHN COMPANY Pyrazolopyrimidine and pyrimidinyl bisphosphonic esters as anti-inflammatories
US6399621B1 (en) * 1999-08-10 2002-06-04 American Cyanamid Company N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1, 5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
TWI252851B (en) * 2003-07-24 2006-04-11 Ferrer Int 7-substituted 3-nitro-pyrazolo[1,5-a]pyrimidines and compositions and methods related thereto
ES2222813B1 (es) * 2003-07-24 2005-12-16 Ferrer Internacional, S.A. N-(3-(3-sustituidas-pirazolo(1,5-a)pirimidin-7-il)-fenil)-sulfonamidas y composiciones y metodos relacionados.
EP1736475A1 (en) 2005-06-21 2006-12-27 Ferrer Internacional, S.A. Halogenated pyrazolo[1,5-a]pyrimidines, processes, uses, compositions and intermediates
DE102005028765B4 (de) * 2005-06-22 2016-01-21 Airbus Operations Gmbh Verfahren zur Herstellung eines Verstärkungsprofils
EP1956021A1 (en) * 2006-10-11 2008-08-13 Ferrer Internacional, S.A. Process for the manufacture of a crystalline pyrazolo[1,5-a]pyrimidine compound

Also Published As

Publication number Publication date
MX2009001149A (es) 2009-03-02
RU2458063C2 (ru) 2012-08-10
AU2007280412A1 (en) 2008-02-07
CN101641359A (zh) 2010-02-03
US8158632B2 (en) 2012-04-17
US20090264448A1 (en) 2009-10-22
CY1110757T1 (el) 2015-06-10
AR062205A1 (es) 2008-10-22
SI2059521T1 (sl) 2010-09-30
JP2009545568A (ja) 2009-12-24
DE602007006966D1 (de) 2010-07-15
EP2059521B1 (en) 2010-06-02
BRPI0715169A2 (pt) 2013-06-11
EP1884516A1 (en) 2008-02-06
ES2346810T3 (es) 2010-10-20
RU2009107734A (ru) 2010-09-10
DK2059521T3 (da) 2010-09-27
TW200815445A (en) 2008-04-01
PL2059521T3 (pl) 2010-11-30
ATE469906T1 (de) 2010-06-15
EP2059521A1 (en) 2009-05-20
KR20090046916A (ko) 2009-05-11
CL2007002262A1 (es) 2008-01-18
WO2008015253A1 (en) 2008-02-07
PT2059521E (pt) 2010-08-26
NO20090972L (no) 2009-04-30
CA2659969A1 (en) 2008-02-07
UY30521A1 (es) 2008-02-29

Similar Documents

Publication Publication Date Title
IL226486A0 (en) Converted pyrazolopyrimidine compounds
ZA201002334B (en) Imidazo
DE602007002700D1 (en) Interventionsfreies frac-system
EP2078282A4 (en) ELECTRONIC COUPONS
EP2033216A4 (en) ELEKTROADHÄSION
DE602007008085D1 (en) Dihydropyrazolopyrimidinonderivate
DE602007014031D1 (en) Luftreifensatz
IL194584A0 (en) Imidazo compounds
EP2093337A4 (en) MULTIPURPOSE PIECE
DE602007002070D1 (en) 2-pyrazincarboxamidderivate
DE602007003855D1 (en) Isothermer reaktor
EP1983992A4 (en) 2-IMINO-BENZIMIDAZOLES
DE602007001601D1 (en) Glasuntersuchung
DE602007006989D1 (en) Spiropiperidinderivate
HK1120803A1 (en) Pyrazolo
AP2008004724A0 (en) Substituted1-yl)-azolin-2-aryl-1-hetaryl-ethane
DE602007011622D1 (en) Penem-prodrugs
EP2084019A4 (en) PAINT SCRAPER
EP2024567A4 (en) TONTAPETE
HK1129105A1 (en) Pyrazolo
EP2007388A4 (en) OPIOPATHIEN
DK1989111T3 (en) Satellitluftbremseapparat
GB0617223D0 (en) Complex
DE502007001126D1 (en) Eiten
AU3514P (en) ARCBENT Arctotis fastuosa

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20140802